Market Movers

Centene Corporation’s Stock Price Plummets to $72.45, Marking a Significant 6.82% Drop

Centene Corporation (CNC)

72.45 USD -5.30 (-6.82%) Volume: 5.83M

Centene Corporation’s stock price stands at 72.45 USD, witnessing a trading session drop of -6.82% with a trading volume of 5.83M, and a year-to-date percentage change of -2.37%, underlining the market’s evolving sentiment towards CNC’s financial performance.


Latest developments on Centene Corporation

Centene Corp (NYSE:CNC) has experienced notable stock price movements recently, due in part to a series of significant financial transactions. Vanguard’s purchase of Centene’s University City office campus, aimed at consolidating Charlotte operations, has caught investor attention. Additionally, increases in short interest up by 8.6% in March signal growing market speculation around Centene’s stock. Despite some daily losses, Centene Corp has outperformed competitors in the market. Investment activities by financial entities such as the State of Alaska Department of Revenue, Blue Trust Inc., Washington Capital Management Inc., IFG Advisory LLC, and Raymond James & Associates, who have all adjusted their holdings in Centene Co., have also played a role in recent stock price movements.


A look at Centene Corporation Smart Scores

FactorScoreMagnitude
Value4
Dividend1
Growth4
Resilience3
Momentum4
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Centene Corporation, a multi-line managed care organization, has been given a strong overall outlook by Smartkarma Smart Scores. The company has received a score of 4 for both value and growth, indicating positive prospects for its financial performance. This is further supported by a score of 3 for resilience, suggesting the company’s ability to withstand potential challenges in the future. Additionally, Centene Corp has received a score of 4 for momentum, indicating a positive trend in its stock performance. However, the company has received a score of 1 for dividend, suggesting a lower potential for shareholder returns. Overall, Centene Corp seems to have a promising long-term outlook based on its Smart Scores.

Centene Corporation is a company that provides Medicaid and Medicaid-related programs through its health plans in multiple states. The company also offers specialty services such as behavioral health, nurse triage, and treatment compliance. According to Smartkarma Smart Scores, Centene Corp has received strong scores for value, growth, resilience, and momentum. This suggests that the company has a positive financial outlook and is well-equipped to handle potential challenges. However, the company has received a lower score for dividends, which may not be as attractive for shareholders looking for immediate returns. Overall, Centene Corp seems to be a strong player in the managed care industry with promising long-term prospects.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars